Chairman and Professor - Donald B. Albers Endowed Chair - Urologic Oncology
Urology
Dr. Michael S. Cookson, MD
|
|
Give Review
Michael Cookson practices Urology. He studied medicine at University of Oklahoma College of Medicine. He received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "Nashville Lifestyles Magazine", "Meaningful Use Stage 1 Certification", "Top MD" and "Fellow (FACS)". Michael Cookson is also a published doctor. He has 42 paper published. The most recent paper is: Castration-Resistant Prostate Cancer: AUA Guideline Amendment. He is registered with Medicare and accepts Medicare payments.
Publications
- Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy.
- Best Evidence Regarding the Superiority or Inferiority of Robot-Assisted Radical Prostatectomy.
- Castration-Resistant Prostate Cancer: AUA Guideline Amendment.
- Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive Bladder cancer, including carcinoma in situ of the Bladder.
- Locoregional small cell carcinoma of the Bladder: clinical characteristics and treatment patterns.
- An Expressed Retrogene of the Master Embryonic Stem Cell Gene POU5F1 Is Associated with Prostate Cancer Susceptibility.
- Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing Tides.
- Racial variation in the quality of surgical care for Bladder cancer.
- Prostate Cancer: Could sensitive PSA assays expedite salvage radiotherapy?
- Challenges in the pathology of non-muscle-invasive Bladder cancer: a dialogue between the urologic surgeon and the pathologist.
- Incidence and Predictors of Understaging in Patients with Clinical T1 Urothelial Carcinoma Undergoing Radical Cystectomy.
- Castration-Resistant Prostate Cancer: AUA Guideline.
- Positive surgical margins at radical Prostatectomy: much ado about nothing?
- Optimization of Initial Prostate Biopsy in Clinical Practice: Sampling, Labeling, and Specimen Processing.
- Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter?
- Salvage robotic assisted laparoscopic radical Prostatectomy: a single institution, 5-year experience.
- Volume outcomes of cystectomy--is it the surgeon or the setting?
- Surgical and chemotherapeutic management of regional lymph nodes in Bladder cancer.
- Racial variation in the quality of surgical care for prostate Cancer.
- ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder.
- ABO Blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma.
- Lymph Node Yield at Radical Cystectomy Predicts Mortality in Node-negative and not Node-positive Patients.
- Reply.
- Psychometric characteristics of a condition-Specific, health-related quality-of-life survey: the FACT-Vanderbilt Cystectomy Index.
- Voiding function in women with orthotopic neoBladder urinary diversion.
- Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage Bladder cancer and increased tumor proliferation.
- Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small Renal cortical tumours treated electively.
- National practice patterns for immediate postoperative instillation of chemotherapy in nonmuscle invasive Bladder cancer.
- Inferior Vena Cava Filter Strut Perforation Discovered During Right Robotic-assisted Laparoscopic Partial Nephrectomy.
- Recovery of urinary function after radical Prostatectomy: identification of trajectory cluster groups.
- National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats.
- Long-term efficacy and tolerability of once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate Cancer.
- Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate Cancer.
- The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for Bladder cancer.
- Predicting the probability of 90-day survival of elderly patients with Bladder cancer treated with radical cystectomy.
- Urinary Collecting System Invasion Is a Predictor for Overall and Disease-Specific Survival in Locally Invasive Renal Cell Carcinoma.
- Oxidative stress measured by urine F2-isoprostane level is associated with prostate Cancer.
- Association of nonsteroidal anti-inflammatory drugs, Prostate specific antigen and Prostate volume.
- Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
- Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined Bladder cancer.
- Effects of obesity and height on Prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men.
Schools
University Of Oklahoma College Of Medicine
University Tex San Antonio
Meml Sloan Kettering Cancer Center
University Of Oklahoma Norman Ok
Procedures Preformed
- AdRenalectomy
- Bladder Surgery, Robotic-Assisted
- Complete Nephrectomy With Robotic Assistance
- Cystectomy
- View All
Conditions Treated
- Balanoposthitis
- Bladder Cancer
- Bladder Infection
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urologic Oncology
- Urology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Nashville Lifestyles Magazine
- Meaningful Use Stage 1 Certification
- Top MD
- Fellow (FACS)
Education
-
Memorial Sloan-Kettering Cancer Center -
University of Texas Health Science Center -
University of Oklahoma College of Medicine
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1528142635 | |
| NPPES Provider LastName | COOKSON | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 731045036 | |
| NPPES Provider State | OK | |
| Specialty Description | Urology | |
| Total Claim Count | 682.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 21.0 | |
| Percent Opioid Claims | 3.08 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1528142635 |
| Last Name Of The Provider | COOKSON |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
Dr. Brian A. Link, MD |
|
Dr. Philip Mosca, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Basel S. Hassoun, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Charles A. McWilliams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Culkin, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Esber S. Samara, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Raj K. Motwani, DO |
|
|
Dr. Gregory Y. Jia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tyler M. Thress, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph Haddad, MD |
|
|
Dr. Philippe Nabbout, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adamantios M. Mellis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan Street, MD |
|
|
Dr. Mohammad Ramadan, MD
This Doctor is OpenDoctor Recommended.
|